PRRT2 and melanoma: Using a proximity ligation assay, which detects close interactions between two target proteins, PKC-θ was shown to exist in proximity to ZEB1 in the nuclei of immunotherapy-resistant PD-1+/CD8+ T cells but not immunotherapy-responsive T cells derived from melanoma patients (Figure 6E).